These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9203437)

  • 21. Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin.
    Heise T; Weyer C; Serwas A; Heinrichs S; Osinga J; Roach P; Woodworth J; Gudat U; Heinemann L
    Diabetes Care; 1998 May; 21(5):800-3. PubMed ID: 9589244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic decompensation in pump users due to lispro insulin precipitation.
    Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA
    BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980
    [No Abstract]   [Full Text] [Related]  

  • 23. Lispro administered by the QS-M Needle-Free Jet Injector generates an earlier insulin exposure.
    Hu J; Shi H; Zhao C; Li X; Wang Y; Cheng Q; Goswami R; Zhen Q; Mei M; Song Y; Yang S; Li Q
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1203-7. PubMed ID: 27267431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study.
    Naik S; Kerr D; Begley J; Morton J
    Diabetes Technol Ther; 2012 Nov; 14(11):1018-22. PubMed ID: 23101952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin pumps and drop in pressure].
    Aanderud L; Hansen EM
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):570-2. PubMed ID: 8209340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of physicochemical variables of regular insulin formulations on their absorption from the subcutaneous tissue.
    Polaschegg E
    Diabetes Res Clin Pract; 1998 Apr; 40(1):39-44. PubMed ID: 9699089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
    Griffin ME; Feder A; Tamborlane WV
    Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Guerci B; Meyer L; Sallé A; Charrié A; Dousset B; Ziegler O; Drouin P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2673-8. PubMed ID: 10443658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of U-500 regular insulin in prefilled syringes.
    Lull ME; Piacentino JJ; Traina AN
    J Am Pharm Assoc (2003); 2013; 53(3):304-6. PubMed ID: 23699679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive RIA for the specific determination of insulin lispro.
    Bowsher RR; Lynch RA; Brown-Augsburger P; Santa PF; Legan WE; Woodworth JR; Chance RE
    Clin Chem; 1999 Jan; 45(1):104-10. PubMed ID: 9895345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.
    de la Peña A; Seger M; Soon D; Scott AJ; Reddy SR; Dobbins MA; Brown-Augsburger P; Linnebjerg H
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):69-75. PubMed ID: 27119580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic fibrillation of fast-acting insulin analogs.
    Woods RJ; Alarcón J; McVey E; Pettis RJ
    J Diabetes Sci Technol; 2012 Mar; 6(2):265-76. PubMed ID: 22538135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    J Diabetes Sci Technol; 2018 May; 12(3):608-613. PubMed ID: 29284290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin.
    ter Braak EW; Woodworth JR; Bianchi R; Cerimele B; Erkelens DW; Thijssen JH; Kurtz D
    Diabetes Care; 1996 Dec; 19(12):1437-40. PubMed ID: 8941480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin lispro: the ideal pump insulin for patients with severe hypoglycemic unawareness?
    Ooi C; Mullen P; Williams G
    Diabetes Care; 1999 Sep; 22(9):1598-9. PubMed ID: 10480541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.